Stay updated on MEDI4736 and Tremelimumab in Gastric Cancer Clinical Trial
Sign up to get notified when there's something new on the MEDI4736 and Tremelimumab in Gastric Cancer Clinical Trial page.

Latest updates to the MEDI4736 and Tremelimumab in Gastric Cancer Clinical Trial page
- Check3 days agoChange DetectedA banner announces NIH website transition updates and says the agency is adopting “Super Intelligence” in place of “Artificial Intelligence” during the transition.SummaryDifference1%

- Check10 days agoChange DetectedThe ClinicalTrials.gov footer now displays revision v3.7.2 instead of v3.7.1. The page continues to show a 403 Forbidden error rather than the study record.SummaryDifference0.2%

- Check17 days agoChange DetectedThe footer revision label changes from v3.7.0 to v3.7.1 on the 403 error page.SummaryDifference0.2%

- Check30 days agoChange DetectedThe page now displays a 403 Forbidden error instead of the study record, blocking access to the study details and attached documents. The error page includes a Home link for navigation.SummaryDifference20%

- Check37 days agoChange DetectedThe page now shows Revision: v3.7.0, replacing Revision: v3.6.6, indicating an updated version of the related documents (e.g., protocol/SAP) without altering the study details.SummaryDifference0.0%

- Check65 days agoChange DetectedSitewide outage warning and the NCBI service delay notice were removed from the page, removing prominent system-status alerts from the study details view.SummaryDifference0.1%

Stay in the know with updates to MEDI4736 and Tremelimumab in Gastric Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the MEDI4736 and Tremelimumab in Gastric Cancer Clinical Trial page.